Articles related to OCULAR SURFACE

Experts reviewing scleral lens care argue that underlying dry eye disease is a frequent but overlooked contributor to visual complaints among scleral lens wearers. The article emphasizes diagnostic evaluation and multimodal management strategies rather than new clinical trial evidence.

TFOS DEWS III proposes a driver-based approach to dry eye disease, emphasizing standardized diagnosis, disease subtyping, and layered treatment strategies matched to underlying mechanisms rather than rigid severity-based escalation.

Inconsistent cataract biometry measurements most commonly reflect ocular surface instability, subtle corneal pathology, or suboptimal measurement conditions rather than random error, and a systematic diagnostic approach before repeating scans can meaningfully improve refractive predictability.

OCT, B-scan ultrasound, and ultrasound biomicroscopy identified distinct structural signatures across hypotony sequelae including maculopathy, choroidal detachment, and cyclodialysis cleft in cases where slit-lamp examination and indirect ophthalmoscopy alone proved insufficient.

Researchers at the National University of Singapore developed a spinach-derived nanotechnology delivering plant photosynthetic machinery into corneal cells via eye drops, demonstrating reversal of corneal damage to near-healthy levels within five days in preclinical models of dry eye disease.

“In discussions with ophthalmologists and optometrists, nearly all say they would choose SLT first if it were their own eye. However, when asked how often their patients receive SLT as initial therapy, most report rates around 10%.” – John Berdahl, MD, Vance Thompson Vision